ArticleExperimental hematology & oncology2025
Correction: IL‑6‑mediated tumorigenicity and antioxidant state in squamous cell carcinoma cells are driven by CD109 via stabilization of IL‑6 receptor‑alpha and activation of STAT3/NRF2 pathway.
Amani Hassan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.